donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > MRNA Moderna > Detailed Quotes

MRNA Moderna

142.920
-2.440-1.68%
Trading Session 06/28 12:27 ET
High
149.790
Open
143.400
Turnover
310.17M
Low
142.420
Pre Close
145.360
Volume
2.12M
Market Cap
56.85B
P/E(TTM)
4.20
52wk High
497.490
Shares
397.76M
P/E(Static)
5.05
52wk Low
115.610
Float Cap
51.44B
Bid/Ask %
-33.33%
Historical High
497.490
Shs Float
359.91M
Volume Ratio
0.83
Historical Low
11.540
Dividend TTM
--
Div Yield TTM
150
P/B
3.33
Dividend LFY
--
Div Yield LFY
104.95%
Turnover Ratio
0.59%
Amplitude
5.07%
Avg Price
146.518
Lot Size
1
Float Cap
51.44B
Bid/Ask %
-33.33%
Historical High
497.490
Shs Float
359.91M
Volume Ratio
0.83
Historical Low
11.540
Dividend TTM
--
P/B
3.33
Dividend LFY
--
Turnover Ratio
0.59%
Amplitude
5.07%
Avg Price
146.518
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency virus, herpes simplex virus, and varicella-zoster virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances with AstraZeneca PLC; Merck & Co., Inc.; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.; Metagenomi, Inc.; the Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici S.P.A. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
CEO: --
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...